Search

MK-677 (ibutamoren) is an orally active, non-peptide growth hormone secretagogue that mimics ghrelin at the GHS-R1a receptor to raise growth hormone and IGF-1. Despite extensive clinical investigation it has never received FDA approval, and recognized effects include increased appetite and reduced insulin sensitivity. It is included here as a widely discussed secretagogue although it is a small molecule rather than a peptide.